cbdMD (YCBD) Net Cash Flow (2016 - 2025)
cbdMD (YCBD) reported Net Cash Flow of $1.1 million for Q4 2025, up 333.59% on a YoY basis from $259851.4 in Q4 2024, and down 6.24% sequentially from $1.2 million in Q3 2025.
cbdMD (YCBD) Net Cash Flow (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Net Cash Flow data on file, last reported at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 333.59% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 204.64% YoY), and the FY2025 full-year result was -$191311.0, down 129.22% from the prior year.
- Net Cash Flow declined to $1.1 million in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $7.4 million in Q3 2021 to a low of -$6.7 million in Q4 2021.
- A 5-year average of -$1.3 million and a median of -$594005.5 in 2024 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 4188.32% in 2021, while the deepest fall reached 2870.81% in 2021.
- Tracing YCBD's Net Cash Flow over 5 years: stood at -$6.7 million in 2021, then soared by 49.85% to -$3.4 million in 2022, then soared by 91.3% to -$293016.0 in 2023, then slumped by 64.61% to -$482336.0 in 2024, then surged by 333.59% to $1.1 million in 2025.
- Business Quant data shows YCBD's Net Cash Flow at $1.1 million in Q4 2025, $1.2 million in Q3 2025, and -$705675.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.13 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | -705,675.00 |
| Jun 30, 2025 | -705,675.00 |
| Mar 31, 2025 | -204,983.00 |
| Mar 31, 2025 | -204,983.00 |
| Dec 31, 2024 | -482,336.00 |
| Dec 31, 2024 | -482,336.00 |
| Sep 30, 2024 | 57,378.00 |
| Sep 30, 2024 | 57,378.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | 600,552.00 |
| Mar 31, 2024 | 600,552.00 |
| Dec 31, 2023 | -293,016.00 |
| Dec 31, 2023 | -293,016.00 |
| Sep 30, 2023 | -1.05 Mn |
| Sep 30, 2023 | -1.05 Mn |